Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
24.15
+0.38 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
24.43
+0.28 (1.14%)
After-hours: Jun 26, 2026, 6:45 PM EDT
Zymeworks Employees
Zymeworks had 264 employees as of December 31, 2025. The number of employees decreased by 22 or -7.69% compared to the previous year.
Employees
264
Change (1Y)
-22
Growth (1Y)
-7.69%
Revenue / Employee
$334,416
Profits / Employee
-$422,453
Market Cap
1.76B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| AbCellera Biologics | 562 |
| Syndax Pharmaceuticals | 298 |
| UroGen Pharma | 298 |
| Capricor Therapeutics | 231 |
| Monte Rosa Therapeutics | 187 |
| Innoviva | 159 |
ZYME News
- 8 days ago - Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery - PRNewsWire
- 12 days ago - Zymeworks presents new clinical data on Phase 1 study of ZW191 - TheFly
- 12 days ago - Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - GlobeNewsWire
- 17 days ago - Zymeworks assumed with a Buy at Truist - TheFly
- 23 days ago - Zymeworks Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Zymeworks authorizes share repurchase program of up to $125M - TheFly
- 6 weeks ago - Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - GlobeNewsWire
- 6 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire